BAGNARDI, VINCENZO
BAGNARDI, VINCENZO
DIPARTIMENTO DI SCIENZE DEL SISTEMA NERVOSO E DEL COMPORTAMENTO
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients
2022-01-01 Wang, M.; Peterson, D. R.; Pagan, E.; Bagnardi, V.; Mazzanti, A.; Mcnitt, S.; Rich, D. Q.; Seplaki, C. L.; Kutyifa, V.; Polonsky, B.; Barsheshet, A.; Kukavica, D.; Rosero, S.; Goldenberg, I.; Priori, S.; Zareba, W.
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome
2019-01-01 Mazzanti, A.; Tenuta, E.; Marino, M.; Pagan, E.; Morini, M.; Memmi, M.; Colombi, B.; Tibollo, V.; Frassoni, S.; Curcio, A.; Raimondo, C.; Maltret, A.; Monteforte, N.; Bloise, R.; Napolitano, C.; Bellazzi, R.; Bagnardi, V.; Priori, S. G.
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3
2016-01-01 Mazzanti, Andrea; Maragna, Riccardo; Faragli, Alessandro; Monteforte, Nicola; Bloise, Raffaella; Memmi, Mirella; Novelli, Valeria; Baiardi, Paola; Bagnardi, Vincenzo; Etheridge, Susan P.; Napolitano, Carlo; Priori, SILVIA GIULIANA
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome
2017-01-01 Mazzanti, A; Maragna, R; Vacanti, Gaetano; Kostopoulou, A; Marino, M; Monteforte, N; Bloise, R; Underwood, K; Tibollo, V; Pagan, E; Napolitano, C; Bellazzi, R; Bagnardi, V; Priori, Sg.
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)
2022-01-01 Mazzanti, Andrea; Trancuccio, Alessandro; Kukavica, Deni; Pagan, Eleonora; Wang, Meng; Mohsin, Muhammad; Peterson, Derick; Bagnardi, Vincenzo; Zareba, Wojciech; Priori, Silvia G
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors' reply
2022-01-01 Mazzanti, Andrea; Trancuccio, Alessandro; Kukavica, Deni; Pagan, Eleonora; Wang, Meng; Mohsin, Muhammed; Peterson, Derick; Bagnardi, Vincenzo; Zareba, Wojciech; Priori, Silvia G
Inter-observer agreement on the morphology of screening-detected lung cancer: beyond pulmonary nodules and masses
2019-01-01 Rampinelli, Cristiano; Minotti, Marta; Ancona, Eleonora; Preda, Lorenzo; Bertolotti, Raffaella; Summers, Paul; Raimondi, Sara; Bagnardi, Vincenzo; Bellomi, Massimo
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome
2018-01-01 Mazzanti, A; Maragna, R; Vacanti, G; Monteforte, N; Bloise, R; Marino, M; Braghieri, L; Gambelli, Patrick; Memmi, Mirella; Pagan, E; Morini, M; Malovini, A; Ortiz, Michael; Sacilotto, L; Bellazzi, R; Monserrat, L; Napolitano, C; Bagnardi, V; Priori, Sg.
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1
2020-01-01 Mazzanti, A.; Guz, D.; Trancuccio, A.; Pagan, E.; Kukavica, D.; Chargeishvili, T.; Olivetti, N.; Biernacka, E. K.; Sacilotto, L.; Sarquella-Brugada, G.; Campuzano, O.; Nof, E.; Anastasakis, A.; Sansone, V. A.; Jimenez-Jaimez, J.; Cruz, F.; Sanchez-Quinones, J.; Hernandez-Afonso, J.; Fuentes, M. E.; Sredniawa, B.; Garoufi, A.; Andrsova, I.; Izquierdo, M.; Marinov, R.; Danon, A.; Exposito-Garcia, V.; Garcia-Fernandez, A.; Munoz-Esparza, C.; Ortiz, M.; Zienciuk-Krajka, A.; Tavazzani, E.; Monteforte, N.; Bloise, R.; Marino, M.; Memmi, M.; Napolitano, C.; Zorio, E.; Monserrat, L.; Bagnardi, V.; Priori, S. G.
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome
2019-01-01 Mazzanti, A.; Ovics, P.; Shauer, A.; Mameli, S.; Marino, M.; Bloise, R.; Monteforte, N.; Raimondo, C.; Maltret, A.; Napolitano, C.; Bagnardi, V.; Priori, S. G.
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy
2022-01-01 Addetia, Karima; Mazzanti, Andrea; Maragna, Riccardo; Monti, Lorenzo; Yamat, Megan; Kukavica, Deni; Pagan, Eleonora; Kishiki, Kanako; Prado, Aldo; Marino, Maira; Bagnardi, Vincenzo; Priori, Silvia; Lang, Roberto M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients | 1-gen-2022 | Wang, M.; Peterson, D. R.; Pagan, E.; Bagnardi, V.; Mazzanti, A.; Mcnitt, S.; Rich, D. Q.; Seplaki, C. L.; Kutyifa, V.; Polonsky, B.; Barsheshet, A.; Kukavica, D.; Rosero, S.; Goldenberg, I.; Priori, S.; Zareba, W. | |
| Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome | 1-gen-2019 | Mazzanti, A.; Tenuta, E.; Marino, M.; Pagan, E.; Morini, M.; Memmi, M.; Colombi, B.; Tibollo, V.; Frassoni, S.; Curcio, A.; Raimondo, C.; Maltret, A.; Monteforte, N.; Bloise, R.; Napolitano, C.; Bellazzi, R.; Bagnardi, V.; Priori, S. G. | |
| Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 | 1-gen-2016 | Mazzanti, Andrea; Maragna, Riccardo; Faragli, Alessandro; Monteforte, Nicola; Bloise, Raffaella; Memmi, Mirella; Novelli, Valeria; Baiardi, Paola; Bagnardi, Vincenzo; Etheridge, Susan P.; Napolitano, Carlo; Priori, SILVIA GIULIANA | |
| Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome | 1-gen-2017 | Mazzanti, A; Maragna, R; Vacanti, Gaetano; Kostopoulou, A; Marino, M; Monteforte, N; Bloise, R; Underwood, K; Tibollo, V; Pagan, E; Napolitano, C; Bellazzi, R; Bagnardi, V; Priori, Sg. | |
| Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) | 1-gen-2022 | Mazzanti, Andrea; Trancuccio, Alessandro; Kukavica, Deni; Pagan, Eleonora; Wang, Meng; Mohsin, Muhammad; Peterson, Derick; Bagnardi, Vincenzo; Zareba, Wojciech; Priori, Silvia G | |
| Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors' reply | 1-gen-2022 | Mazzanti, Andrea; Trancuccio, Alessandro; Kukavica, Deni; Pagan, Eleonora; Wang, Meng; Mohsin, Muhammed; Peterson, Derick; Bagnardi, Vincenzo; Zareba, Wojciech; Priori, Silvia G | |
| Inter-observer agreement on the morphology of screening-detected lung cancer: beyond pulmonary nodules and masses | 1-gen-2019 | Rampinelli, Cristiano; Minotti, Marta; Ancona, Eleonora; Preda, Lorenzo; Bertolotti, Raffaella; Summers, Paul; Raimondi, Sara; Bagnardi, Vincenzo; Bellomi, Massimo | |
| Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome | 1-gen-2018 | Mazzanti, A; Maragna, R; Vacanti, G; Monteforte, N; Bloise, R; Marino, M; Braghieri, L; Gambelli, Patrick; Memmi, Mirella; Pagan, E; Morini, M; Malovini, A; Ortiz, Michael; Sacilotto, L; Bellazzi, R; Monserrat, L; Napolitano, C; Bagnardi, V; Priori, Sg. | |
| Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 | 1-gen-2020 | Mazzanti, A.; Guz, D.; Trancuccio, A.; Pagan, E.; Kukavica, D.; Chargeishvili, T.; Olivetti, N.; Biernacka, E. K.; Sacilotto, L.; Sarquella-Brugada, G.; Campuzano, O.; Nof, E.; Anastasakis, A.; Sansone, V. A.; Jimenez-Jaimez, J.; Cruz, F.; Sanchez-Quinones, J.; Hernandez-Afonso, J.; Fuentes, M. E.; Sredniawa, B.; Garoufi, A.; Andrsova, I.; Izquierdo, M.; Marinov, R.; Danon, A.; Exposito-Garcia, V.; Garcia-Fernandez, A.; Munoz-Esparza, C.; Ortiz, M.; Zienciuk-Krajka, A.; Tavazzani, E.; Monteforte, N.; Bloise, R.; Marino, M.; Memmi, M.; Napolitano, C.; Zorio, E.; Monserrat, L.; Bagnardi, V.; Priori, S. G. | |
| Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome | 1-gen-2019 | Mazzanti, A.; Ovics, P.; Shauer, A.; Mameli, S.; Marino, M.; Bloise, R.; Monteforte, N.; Raimondo, C.; Maltret, A.; Napolitano, C.; Bagnardi, V.; Priori, S. G. | |
| Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy | 1-gen-2022 | Addetia, Karima; Mazzanti, Andrea; Maragna, Riccardo; Monti, Lorenzo; Yamat, Megan; Kukavica, Deni; Pagan, Eleonora; Kishiki, Kanako; Prado, Aldo; Marino, Maira; Bagnardi, Vincenzo; Priori, Silvia; Lang, Roberto M |